Political rhetoric surrounding drug prices could slam biotech companies like Celgene and Incyte as the election season ramps up, an analyst said Monday.
Updated: 07/24/2019 03:00A
A few weeks ago, one of my coworkers at Business Insider created a Slack channel called #lunch-buddy. Anyone who joined the channel would be randomly ...
Updated: 01/28/2019 01:24P